In most AML cell lines, cell proliferation was inhibited by both ABZ and PBZ; however, a marked inhibition was observed in PBZ-treated samples, irrespective of the FAB classifications and genetic abnormalities of AML cells (Fig. 4a, Supplementary Fig. 2). This evidence concerns the gene FANCB and acute myeloid leukemia.